Zymeworks (ZYME) Interest & Investment Income (2021 - 2026)
Zymeworks' (ZYME) quarterly Interest & Investment Income came in at $2.7 million in Q1 2026, down 20.82% year-on-year from $3.4 million in Q1 2025, and down 8.87% quarter-over-quarter from $3.0 million in Q4 2025.
Zymeworks (ZYME) Interest & Investment Income (2021 - 2026) Analysis & Trends
Zymeworks has disclosed Interest & Investment Income across 6 years of filings, most recently posting $2.7 million for Q1 2026.
- Interest & Investment Income for Q1 2026 came in at $2.7 million, down 20.82% year-over-year; the trailing twelve-month figure through Mar 2026 was $12.6 million (down 27.54% YoY), and the FY2025 annual result was $13.4 million, down 33.03% from the prior year.
- Interest & Investment Income came in at $2.7 million for Q1 2026 at Zymeworks, down from $3.0 million in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $5.9 million in Q1 2024 to a low of $302000.0 in Q1 2022.
- The 5-year median for Interest & Investment Income is $3.5 million (2025), against an average of $3.5 million.
- Across the five-year window, Interest & Investment Income soared 1491.06% in 2023 and slumped 42.16% in 2025, its largest moves.
- Zymeworks' Interest & Investment Income stood at $1.7 million in 2022, then soared by 191.34% to $5.0 million in 2023, then decreased by 19.15% to $4.1 million in 2024, then dropped by 27.12% to $3.0 million in 2025, then fell by 8.87% to $2.7 million in 2026.
- The last three Interest & Investment Income figures came in at $2.7 million (Q1 2026), $3.0 million (Q4 2025), and $3.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 597,319.59 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 305,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -14.79 Mn |
| 10 | Zymeworks | 1.73 Bn | 1.36 Bn | - | 2.71 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.71 Mn |
| Dec 31, 2025 | 2.98 Mn |
| Sep 30, 2025 | 3.53 Mn |
| Jun 30, 2025 | 3.43 Mn |
| Mar 31, 2025 | 3.42 Mn |
| Dec 31, 2024 | 4.08 Mn |
| Sep 30, 2024 | 4.79 Mn |
| Jun 30, 2024 | 5.15 Mn |
| Mar 31, 2024 | 5.92 Mn |
| Dec 31, 2023 | 5.05 Mn |
| Sep 30, 2023 | 5.03 Mn |
| Jun 30, 2023 | 4.83 Mn |
| Mar 31, 2023 | 4.81 Mn |
| Dec 31, 2022 | 1.73 Mn |
| Sep 30, 2022 | 1.13 Mn |
| Jun 30, 2022 | 436,000.00 |
| Mar 31, 2022 | 302,000.00 |
| Dec 31, 2021 | 296,000.00 |
| Sep 30, 2021 | 340,000.00 |